139 related articles for article (PubMed ID: 31819533)
1.
Yang G; Lu YB; Guan QL
Onco Targets Ther; 2019; 12():10523-10534. PubMed ID: 31819533
[TBL] [Abstract][Full Text] [Related]
2. HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway.
Yang G; Su F; Han BX; Su HX; Guo CH; Yu SH; Guan QL; Hou XM
Biochem Pharmacol; 2024 May; 223():116133. PubMed ID: 38494066
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
4. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
[TBL] [Abstract][Full Text] [Related]
5. MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells.
Zhu Y; Sun JM; Sun ZC; Chen FJ; Wu YP; Hou XY
Front Oncol; 2020; 10():600762. PubMed ID: 33692940
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Eps8 blocks migration and invasion in human glioblastoma cell lines.
Cattaneo MG; Cappellini E; Vicentini LM
Exp Cell Res; 2012 Sep; 318(15):1901-12. PubMed ID: 22683923
[TBL] [Abstract][Full Text] [Related]
7. FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling.
Wen Q; Jiao X; Kuang F; Hou B; Zhu Y; Guo W; Sun G; Ba Y; Yu D; Wang D; Zhang F; Qiao HC; Wang S; Tang S; Qiao H
EBioMedicine; 2019 Feb; 40():198-209. PubMed ID: 30738830
[TBL] [Abstract][Full Text] [Related]
8. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
[TBL] [Abstract][Full Text] [Related]
9. Midkine promotes glioblastoma progression via PI3K-Akt signaling.
Hu B; Qin C; Li L; Wei L; Mo X; Fan H; Lei Y; Wei F; Zou D
Cancer Cell Int; 2021 Sep; 21(1):509. PubMed ID: 34556138
[TBL] [Abstract][Full Text] [Related]
10. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
Ni H; Ji D; Huang Z; Li J
Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
[TBL] [Abstract][Full Text] [Related]
11. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
Yang H; Song Z; Wu X; Wu Y; Liu C
Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
[TBL] [Abstract][Full Text] [Related]
14. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
Ni H; Wang K; Xie P; Zuo J; Liu W; Liu C
Cell Mol Neurobiol; 2021 Jan; 41(1):79-90. PubMed ID: 32236901
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived exosomal microRNA-7-5p enhanced by verbascoside inhibits biological behaviors of glioblastoma
Wang H; Feng J; Ao F; Tang Y; Xu P; Wang M; Huang M
Mol Ther Oncolytics; 2021 Mar; 20():569-582. PubMed ID: 33768139
[TBL] [Abstract][Full Text] [Related]
17. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility.
Wang H; Teh MT; Ji Y; Patel V; Firouzabadian S; Patel AA; Gutkind JS; Yeudall WA
Carcinogenesis; 2010 Jun; 31(6):1132-41. PubMed ID: 20351091
[TBL] [Abstract][Full Text] [Related]
18. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
[TBL] [Abstract][Full Text] [Related]
19. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
20. A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.
Li M; Yang J; Zhang L; Tu S; Zhou X; Tan Z; Zhou W; He Y; Li Y
J Exp Clin Cancer Res; 2019 May; 38(1):211. PubMed ID: 31118055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
